MIT 0. In the latest skirmish between West Coast and East Coast over the #1 disruptive biotechnology, CRISPR, it is advantage ...

Holy Moley Rocky! Pipsqueak pharmacy wins slam dunk verdict against Big Pharma—re: Ozempic and Wegovy?! Incredible story with ...

Massachusetts, are suing the Trump administration over NIH cuts alleging they violate law and principle. Is it too late for ...

Dr. Kingsley R. Chin, the Founder, President and CEO of SpineFrontier, Inc., pleaded guilty on May 15, 2025, to one count of false statements to the Centers for Medicare & Medicaid Services’ (CMS) ...

In a groundbreaking advancement for the orthopedic device industry, Sawbones and Numalogics, Inc. are proud to announce that ...

A new study from the University of Missouri School of Medicine has found evidence that NFL players are returning to play too soon following knee injuries. This new work, titled “National Football ...

It’s something you can’t buy more of. Answer: TIME. But not just clock time. Biologic Time. Very innovative research tackles ...

ATEC just exceeded Wall Street’s estimates. EPS, however, lagged expectations. Alphatec Holdings, Inc., reported Q1 2025 sales of $169 million, up 22%. Operating losses, however, rose 2% to -$44.3 ...

TKA patients should receive a higher DRG classification—469 vs 470. Why? Umm—They Cost More? Here’s the data—from a new NYU ...

Stryker Corporation’s opening quarter of 2025 was, to paraphrase one Wall Street analysts, a “top, middle and bottom beat” ...

ZBH’s Q1 2025 report. That’s the sign of improved operating efficiencies. The ZBH engine is running well. Good start for the ...